International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
2014 · The Lancet Oncology · 4,761 citations
https://doi.org/10.1016/s1470-2045(14)70442-5
O
Ola Landgren
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.4K
Papers
43.2K
Citations
102
h-index
440
i10-index
Ola Landgren is an academic researcher from University of Miami. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Chronic Lymphocytic Leukemia Research. The author has an h-index of 102, co-authored 1206 publications.
ORCID: 0000-0001-6485-4839Papers by this author
worksInternational Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
2016 · The Lancet Oncology · 2,843 citations
https://doi.org/10.1016/s1470-2045(16)30206-6
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
2012 · Leukemia · 377 citations
https://doi.org/10.1038/leu.2012.336
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up
2013 · Haematologica · 327 citations
https://doi.org/10.3324/haematol.2013.092460
IMWG consensus on maintenance therapy in multiple myeloma
2012 · Blood · 194 citations
https://doi.org/10.1182/blood-2011-11-374249
The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
2015 · Blood Cancer Journal · 128 citations
https://doi.org/10.1038/bcj.2015.32
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat